We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.81B
| $1.8M | ﹤0.01% |
44,354
+3,038
| +7% | +$120K |
2022 Q4
14 quarters
|
|
2177
CRISPR Therapeutics
CRSP
$4.78B
| $1.8M | ﹤0.01% |
33,065
-4,543
| -12% | -$239K |
2018 Q3
31 quarters
|
|
2178
CONMED
CNMD
$1.48B
| $1.8M | ﹤0.01% |
54,858
+20,210
| +58% | +$728K |
2025 Q2
4 quarters
|
|
2179
Jakks Pacific
JAKK
$349M
| $1.79M | ﹤0.01% |
77,104
-1,312
| -2% | -$29.1K |
2024 Q2
8 quarters
|
|
2180
Talos Energy
TALO
$3.07B
| $1.79M | ﹤0.01% |
138,868
+31,003
| +29% | +$462K |
2024 Q1
9 quarters
|
|
2181
FMC
FMC
$786M
| $1.79M | ﹤0.01% |
155,818
-3,171
| -2% | -$44.2K |
2015 Q3
43 quarters
|
|
2182
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.16B
| $1.79M | ﹤0.01% |
91,733
+1,053
| +1% | +$20.6K |
2021 Q2
20 quarters
|
|
2183
Evolent Health
EVH
$543M
| $1.79M | ﹤0.01% |
330,017
-17,355
| -5% | -$66.5K |
2023 Q4
10 quarters
|
|
2184
iShares A.I. Innovation and Tech Active ETF
BAI
$12.4B
| $1.78M | ﹤0.01% |
33,849
+9,926
| +41% | +$451K |
2025 Q3
3 quarters
|
|
2185
Concentra Group Holdings
CON
$5.01B
| $1.78M | ﹤0.01% |
59,954
+17,131
| +40% | +$426K |
2024 Q4
6 quarters
|
|
2186
Integra LifeSciences
IART
$926M
| $1.77M | ﹤0.01% |
98,772
+31,056
| +46% | +$434K |
2024 Q4
6 quarters
|
|
2187
Asana
ASAN
$2.75B
| $1.77M | ﹤0.01% |
253,197
+117,790
| +87% | +$791K |
2025 Q3
3 quarters
|
|
2188
Adaptive Biotechnologies
ADPT
$4.07B
| $1.77M | ﹤0.01% |
82,533
-910
| -1% | -$13.9K |
2020 Q1
25 quarters
|
|
2189
Biohaven
BHVN
$2.1B
| $1.76M | ﹤0.01% |
118,599
+62,486
| +111% | +$673K |
2022 Q4
14 quarters
|
|
2190
USA Rare Earth Inc
USAR
$3.5B
| $1.76M | ﹤0.01% |
81,706
+35,872
| +78% | +$818K |
2025 Q3
3 quarters
|
|
2191
iShares US Transportation ETF
IYT
$2B
| $1.76M | ﹤0.01% |
20,306
-2,350
| -10% | -$192K |
2015 Q3
43 quarters
|
|
2192
NYLIM MacKay Muni Intermediate ETF
MMIT
$1.59B
| $1.76M | ﹤0.01% |
72,243
-1,687
| -2% | -$41K |
2025 Q4
2 quarters
|
|
2193
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.35B
| $1.75M | ﹤0.01% |
11,983
-57
| -0.5% | -$7.9K |
2022 Q4
14 quarters
|
|
2194
WisdomTree US SmallCap Earnings Fund
EES
$685M
| $1.75M | ﹤0.01% |
25,857
-223
| -0.9% | -$14.2K |
2020 Q1
25 quarters
|
|
2195
Service Corp International
SCI
$11.4B
| $1.75M | ﹤0.01% |
23,065
-10,033
| -30% | -$785K |
2013 Q2
52 quarters
|
|
2196
Zions Bancorporation
ZION
$9.7B
| $1.75M | ﹤0.01% |
25,313
+2,240
| +10% | +$141K |
2015 Q3
43 quarters
|
|
2197
iShares ESG Advanced MSCI USA ETF
USXF
$1.41B
| $1.75M | ﹤0.01% |
25,210
+7,813
| +45% | +$506K |
2023 Q4
10 quarters
|
|
2198
First Trust Enhanced Equity Income Fund
FFA
$442M
| $1.75M | ﹤0.01% |
78,215
-1,513
| -2% | -$33.6K |
2024 Q4
6 quarters
|
|
2199
Somnigroup International
SGI
$14.9B
| $1.75M | ﹤0.01% |
22,307
-3,364
| -13% | -$247K |
2022 Q3
15 quarters
|
|
2200
Energizer
ENR
$1.55B
| $1.74M | ﹤0.01% |
81,363
+40,846
| +101% | +$778K |
2022 Q4
14 quarters
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.